Target Audience and Goal Statement
This activity is intended for primary care physicians, cardiologists, and other healthcare professionals who treat patients
with or at risk for atrial fibrillation (AF).
The goal of this activity is to provide an update on strategies to improve detection of AF in primary care practice patients.
Upon completion of this activity, participants will have increased knowledge regarding the:
- Patient assessment criteria to detect AF in the primary care setting
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Moderator

-
Keith A. A. Fox, MBChB, FRCP, FMedSci
Professor of Cardiology, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom
Disclosures
Disclosure: Keith A. A. Fox, MBChB, FRCP, FMedSci, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Bayer AG; Janssen Pharmaceuticals; Regeneron Pharmaceuticals,
Inc.; Sanofi
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Bayer AG; GlaxoSmithKline; Janssen
Pharmaceuticals
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bayer AG; Janssen Pharmaceuticals; Regeneron Pharmaceuticals,
Inc.; Sanofi
Dr Fox does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for
use in the United States.
Dr Fox does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA
for use in the United States.
Panelists

-
Christian T. Ruff, MD, MPH
Assistant Professor of Medicine, TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachus
Disclosures
Disclosure: Christian T. Ruff, MD, MPH, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Portola
Pharmaceuticals, Inc.
Received grants for clinical research from: Daiichi Sankyo, Inc.
Dr Ruff does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the
FDA for use in the United States.
Dr Ruff does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the
FDA for use in the United States.

-
Charles P. Vega, MD
Clinical Professor, Family Medicine, School of Medicine, University of California, Irvine
Disclosures
Disclosure: Charles P. Vega, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Served as a speaker or a member of a speakers bureau for: Shire
Dr Vega does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the
FDA for use in the United States.
Dr Vega does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the
FDA for use in the United States.
Steering Committee
-
Keith A. A. Fox, MBChB, FRCP, FMedSci
-
Jan Beyer-Westendorf, MD
Assistant Professor, University Hospital Carl Gustav Carus der Technische Universität Dresden, Dresden, Germany
Disclosures
Disclosure: Jan Beyer-Westendorf, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.;
LEO Pharma; Pfizer Inc
Served as a speaker or a member of a speakers bureau for: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals,
Inc.; Daiichi Sankyo, Inc.; LEO Pharma; Pfizer Inc
Received grants for clinical research from: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.;
Daiichi Sankyo, Inc.; Pfizer Inc
-
Graeme J. Hankey, MBBS, MD, FRACP, FRCP, FRCPE
Winthrop Professor of Neurology, School of Medicine and Pharmacology, The University of Western Australia; Consultant Neurologist,
Department of Neurology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Disclosures
Disclosure: Graeme J. Hankey, MBBS, MD, FRACP, FRCP, FRCPE, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Johnson
& Johnson Pharmaceutical Research & Development, L.L.C.
Served as a speaker or a member of a speakers bureau for: Bayer HealthCare Pharmaceuticals
-
Gilles Montalescot, MD, PhD
Professor of Cardiology, Institut de Cardiologie, Hôpital la Pitié-Salpêtrière, Paris, France
Disclosures
Disclosure: Gilles Montalescot, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Accumetrics, Inc.; AstraZeneca Pharmaceuticals LP; Bayer HealthCare Pharmaceuticals;
BIOTRONIK; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; GlaxoSmithKline; Iroko Pharmaceuticals,
LLC; Lilly; Medtronic, Inc.; Menarini; Novartis Pharmaceuticals Corporation; Pfizer Inc; Roche; Sanofi; The Medicines Company
Received grants for clinical research from: Abbott Laboratories; Accumetrics, Inc.; AstraZeneca Pharmaceuticals LP; BIOTRONIK;
Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Lilly; Medtronic, Inc.; Menarini; Nanosphere, Inc.; Pfizer Inc; Roche;
The Medicines Company
-
Christian T. Ruff, MD, MPH
Editor
CME Reviewer
Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories; HeartWare International, Inc.; Medtronic, Inc.; Thoratec Corporation
Accreditation Statements
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC),
to provide continuing education for the healthcare team.
For Physicians
-
Medscape, LLC designates this enduring material for a maximum of 0.5
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.